FPH Full-year Results Preview: Grab rewards by guessing the closing price!

Ahead of the release of its results, let's now take a look at what the market is expecting from the FPH.

Headquartered in New Zealand, Fisher & Paykel Healthcare is a medical device company that specializes in manufacturing and marketing products and systems for respiratory care.

During five years of share price growth, FPH achieved compound earnings per share (EPS) growth of 4.4% per year. This EPS growth is slower than the share price growth of 12% per year, over the same period. This suggests that market participants hold the company in higher regard, these days. That's not necessarily surprising considering the five-year track record of earnings growth. This favorable sentiment is reflected in its (fairly optimistic) P/E ratio of 63.47.

Ahead of the March 31 end to its financial year, the company has revealed an upgrade to guidance but it also disclosed that it is facing a hit from a potential fall in property values (which will be a non-cash item in the results).

The company said its full year guidance previously provided on November 29 last year was based on a "NZ:US exchange rate of 58 cents, was for operating revenue to be approximately $1.7 billion and net profit after tax to be in the range of approximately $250 million to $260 million."

FPH is releasing its full-year results on May 29, before the Australian stock market closes. How will the market react to the company's results on the day?

An equal share of 2,000 points: For mooers who correctly guess the price range of  FPH's closing price at 16 PM AEST May 29.

Rewards will be distributed within 7-14 working days after the result's announcement.

Rewards can be used to exchange gifts at the Rewards Club (moomoo app>> Me>> Redeem Points).

The selection is based on post quality, originality, and user engagement.